P. Brett

Y. Suputtamongkol, W. Chaowagul, D. Woods, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice

Jennifer L. Dankmeyer, D. DeShazer, C. Klimko, 2022, Frontiers in Microbiology.

Optimal Diagnostic Workup for Patients with Suspected Melioidosis

A. Hoffmaster, P. Baccam, K. Brown, 2020 .

Melioidosis Diagnostic Workshop, 2013

A. Hoffmaster, P. Baccam, A. Simpson, 2015, Emerging infectious diseases.

Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM

T. West, M. Burtnick, P. Brett, 2021, Frontiers in Immunology.

Children with asymptomatic coronavirus disease-19 (COVID-19): Insights from 2-to 15-year-old cases

D. Caro, P. Brett, S. Wiggins, 2020 .

Consensus on the Development of Vaccines against Naturally Acquired Melioidosis

D. Altmann, A. Torres, G. Bancroft, 2015, Emerging infectious diseases.

Molecular Characterization of Genetic Loci Required for Secretion of Exoproducts in Burkholderia pseudomallei

D. DeShazer, D. Woods, M. Burtnick, 1999, Journal of bacteriology.

Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis.

D. Aucoin, R. Lanzetta, A. Molinaro, 2015, ACS chemical biology.

Melioidosis patient serum-reactive synthetic tetrasaccharides bearing the predominant epitopes of Burkholderia pseudomallei and Burkholderia mallei O-antigens.

M. Burtnick, P. Brett, Charles Gauthier, 2019, Organic & biomolecular chemistry.

Isolation and characterization of Pseudomonas pseudomallei flagellin proteins

D. Woods, P. Brett, D. Mah, 1994, Infection and immunity.

Colony Morphology Variation of Burkholderia pseudomallei Is Associated with Antigenic Variation and O-Polysaccharide Modification

P. Azadi, S. Peacock, M. Holden, 2015, Infection and Immunity.

Evaluation of two different vaccine platforms for immunization against melioidosis and glanders

Jennifer L. Dankmeyer, S. Welkos, D. DeShazer, 2022, Frontiers in Microbiology.

Melioidosis: molecular aspects of pathogenesis

D. DeShazer, M. Burtnick, P. Brett, 2014, Expert review of anti-infective therapy.

Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC

A. Torres, M. Burtnick, P. Brett, 2022, Infection and immunity.

Identification of Peptides that Mimic N. meningitidis LOS Epitopes Via the Use of Combinatorial Phage-Display Libraries.

I. Feavers, B. Charalambous, P. Brett, 2001, Methods in molecular medicine.

Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates

D. Woods, P. Brett, 1996, Infection and immunity.

Use of Rapid Enzyme-Linked Immunosorbent Assays for Serological Screening of Melioidosis in Myanmar.

T. M. Hlaing, M. Burtnick, P. Brett, 2018, The American journal of tropical medicine and hygiene.

pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells

S. Lockett, D. DeShazer, A. Friedlander, 2016, Infection and Immunity.

iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages

H. Su, F. Gherardini, M. Burtnick, 2007, Cellular microbiology.

Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.

P. Azadi, M. Burtnick, P. Brett, 2013, Carbohydrate research.

Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.

P. Azadi, M. Burtnick, P. Brett, 2012, Carbohydrate research.

Development of novel O-polysaccharide based glycoconjugates for immunization against glanders

R. M. Wooten, P. Azadi, R. Titball, 2012, Front. Cell. Inf. Microbio..

Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders

P. Azadi, H. Schweizer, M. Burtnick, 2012, Front. Cell. Inf. Microbio..

Structural analysis of capsular polysaccharides expressed by Burkholderia mallei and Burkholderia pseudomallei.

P. Azadi, M. Burtnick, P. Brett, 2012, Carbohydrate research.

The type II O‐antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence

D. DeShazer, D. Woods, P. Brett, 1998, Molecular microbiology.

Functional Activities of O-Polysaccharide and Hemolysin Coregulated Protein 1 Specific Antibodies Isolated from Melioidosis Patients

M. Burtnick, P. Brett, N. Chantratita, 2022, Infection and immunity.

Burkholderia pseudomallei Capsular Polysaccharide Conjugates Provide Protection against Acute Melioidosis

A. Scott, E. Williamson, M. Burtnick, 2014, Infection and Immunity.

Burkholderia pseudomallei capsular polysaccharide conjugates provide protection

A. Scott, M. Burtnick, P. Brett, 2014 .

Burkholderia thailandensis oacA Mutants Facilitate the Expression of Burkholderia mallei-Like O Polysaccharides

D. DeShazer, P. Azadi, D. Woods, 2010, Infection and Immunity.

The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis.

D. Woods, M. Burtnick, P. Brett, 2003, FEMS microbiology letters.

Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies

M. Perry, W. Chaowagul, P. Brett, 1997, Infection and immunity.

Melioidosis Chapter 9 MELIOIDOSIS

N. Vietri, P. Brett, D. David, 2018 .

Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes

P. Azadi, F. Gherardini, M. Burtnick, 2007, Molecular microbiology.

Immune response to recombinant Burkholderia pseudomallei FliC

S. Dunachie, M. Burtnick, P. Brett, 2018, PloS one.

Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene

R. Carlyon, D. DeShazer, D. Woods, 1997, Journal of bacteriology.

Thermoregulation of Biofilm Formation in Burkholderia pseudomallei Is Disrupted by Mutation of a Putative Diguanylate Cyclase

D. Aucoin, H. Schweizer, N. Marlenee, 2016, Journal of bacteriology.

Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis

T. West, D. Aucoin, N. Day, 2021, PLoS neglected tropical diseases.

Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure

P. Keim, B. Currie, Heidie M. Hornstra, 2018, bioRxiv.

Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.

D. DeShazer, D. Woods, P. Brett, 1998, International journal of systematic bacteriology.

Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains

D. DeShazer, D. Woods, P. Brett, 1997, Epidemiology and Infection.

Molecular and Physical Characterization of Burkholderia mallei O Antigens

D. Woods, M. Burtnick, P. Brett, 2002, Journal of bacteriology.

A Rapid Immunochromatography Test Based on Hcp1 Is a Potential Point-of-Care Test for Serological Diagnosis of Melioidosis

G. Lertmemongkolchai, N. Indrawattana, D. Limmathurotsakul, 2018, Journal of Clinical Microbiology.

Burkholderia mallei and Burkholderia pseudomallei Cluster 1 Type VI Secretion System Gene Expression Is Negatively Regulated by Iron and Zinc

M. Burtnick, P. Brett, 2013, PloS one.

The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei

D. DeShazer, S. Peacock, S. Harding, 2011, Infection and Immunity.

Burkholderia mallei tssM Encodes a Putative Deubiquitinase That Is Secreted and Expressed inside Infected RAW 264.7 Murine Macrophages

M. Schell, D. DeShazer, K. Wilkinson, 2009, Infection and Immunity.

Proteomic Analysis of the Burkholderia pseudomallei Type II Secretome Reveals Hydrolytic Enzymes, Novel Proteins, and the Deubiquitinase TssM

D. DeShazer, M. Burtnick, P. Brett, 2014, Infection and Immunity.

Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.

Edouard E Galyov, Paul J Brett, David DeShazer, 2010, Annual review of microbiology.

Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis

Laura A. Muruato, D. DeShazer, A. Torres, 2017, Infection and Immunity.

Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei

Laura A. Muruato, Christopher L. Hatcher, J. Samuel, 2017, Clinical and Vaccine Immunology.

The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis.

D. Woods, M. Burtnick, P. Brett, 2003, FEMS microbiology letters.

Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei

N. Day, S. Khusmith, D. Limmathurotsakul, 2016, Journal of Clinical Microbiology.

Development of a Prototype Lateral Flow Immunoassay (LFI) for the Rapid Diagnosis of Melioidosis

Direk Limmathurotsakul, Paul J. Brett, Mark A. Hubbard, 2014, PLoS neglected tropical diseases.

Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosis

S. Dunachie, M. Burtnick, P. Brett, 2017, PLoS neglected tropical diseases.

Identification of Circulating Bacterial Antigens by In Vivo Microbial Antigen Discovery

D. Aucoin, S. Peacock, T. Kozel, 2011, mBio.

Development of Immunoassays for Burkholderia pseudomallei Typical and Atypical Lipopolysaccharide Strain Typing

P. Keim, D. Aucoin, C. Allender, 2017, The American journal of tropical medicine and hygiene.

A nonsense mutation in TLR5 is associated with survival and reduced IL-10 and TNF-α levels in human melioidosis

T. West, N. Day, D. Limmathurotsakul, 2017, PLoS neglected tropical diseases.

Characterization of Oligopeptides That Cross-react with Carbohydrate-specific Antibodies by Real Time Kinetics, In-solution Competition Enzyme-linked Immunosorbent Assay, and Immunological Analyses*

I. Feavers, B. Charalambous, P. Brett, 2002, The Journal of Biological Chemistry.

Prospective Analysis of Antibody Diagnostic Tests and TTS1 Real-Time PCR for Diagnosis of Melioidosis in Areas Where It Is Endemic

T. West, M. Burtnick, P. Brett, 2023, Journal of clinical microbiology.

Treponema denticola TroR is a manganese- and iron-dependent transcriptional repressor

F. Gherardini, M. Burtnick, P. Brett, 2008, Molecular microbiology.

Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients

T. West, N. Day, P. Ekchariyawat, 2019, Scientific Reports.

Retrospective Analysis of Fever and Sepsis Patients from Cambodia Reveals Serological Evidence of Melioidosis.

M. Prouty, K. Schully, J. Lawler, 2018, The American journal of tropical medicine and hygiene.

In vivo Distribution and Clearance of Purified Capsular Polysaccharide from Burkholderia pseudomallei in a Murine Model

Sujata G Pandit, D. Aucoin, M. Burtnick, 2016, PLoS neglected tropical diseases.

Current studies on the pathogenesis of melioidosis.

D. DeShazer, D. Woods, M. Burtnick, 1999, Microbes and infection.

Evaluation of Polysaccharide-Based Latex Agglutination Assays for the Rapid Detection of Antibodies to Burkholderia pseudomallei

N. Day, D. Limmathurotsakul, M. Burtnick, 2015, The American journal of tropical medicine and hygiene.

Insights into the complex regulation of rpoS in Borrelia burgdorferi

J. S. Downey, J. Frye, T. Hoover, 2007, Molecular microbiology.

The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei

D. DeShazer, S. Peacock, M. Burtnick, 2011, Infection and Immunity.

Burkholderia mallei Cluster 1 Type VI Secretion Mutants Exhibit Growth and Actin Polymerization Defects in RAW 264.7 Murine Macrophages

D. DeShazer, F. Gherardini, M. Burtnick, 2009, Infection and Immunity.

Molecular and Physical Characterization of Burkholderia mallei O Antigens

D. Woods, M. Burtnick, P. Brett, 2002, Journal of bacteriology.

Identification of Burkholderia cepacia strains that express a Burkholderia pseudomallei-like capsular polysaccharide

D. Limmathurotsakul, M. Burtnick, P. Brett, 2024, Microbiology spectrum.

Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic Burkholderia spp. facilitates TnphoA mutagenesis.

M. Burtnick, P. Brett, D. Watanabe, 2001, Microbiology.

Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.

P. Azadi, M. Burtnick, P. Brett, 2012, Carbohydrate research.